Utilization of Mutational Analysis (MA) in Gastrointestinal Stromal Tumor (GIST) Management in British Columbia (BC) Between January 2008 to December 2017: a Retrospective Population-Based Study-Reference-Cited by-同舟云学术

Utilization of Mutational Analysis (MA) in Gastrointestinal Stromal Tumor (GIST) Management in British Columbia (BC) Between January 2008 to December 2017: a Retrospective Population-Based Study

Published:2021-09-06 Issue: Volume: Page:
ISSN:1941-6628
Container-title:Journal of Gastrointestinal Cancer
language:en
Short-container-title:J Gastrointest Canc

Author:

Patterson Tiffany,Chai Jocelyn,Li Haocheng,de bruyns Angeline,Cleversey Chantell,Lee Cheng-Han,Yip Steven,Simmons Christine,Hart Jason,Pollock Phil,Holloway Caroline,Truong Pauline,Feng Xiaolan^ORCID

Funder

Glenita Mungcal GIST research award

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s12029-021-00682-2.pdf

Reference23 articles.

1. Heinrich MC, Jones RL, von Mehren M, Schöffski P, Serrano C, Kang YK, et al. Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial. Lancet Oncol [Internet]. 2020 [cited 2021 Jan 2];21(7):935–46. Available from: https://pubmed.ncbi.nlm.nih.gov/32615108/

2. Blay JY, Serrano C, Heinrich MC, Zalcberg J, Bauer S, Gelderblom H, et al. Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Oncol [Internet]. 2020 [cited 2021 Mar 1];21(7):923–34. Available from: https://pubmed.ncbi.nlm.nih.gov/32511981/

3. Schöffski P, Mir O, Kasper B, Papai Z, Blay JY, Italiano A, et al. Activity and safety of the multi-target tyrosine kinase inhibitor cabozantinib in patients with metastatic gastrointestinal stromal tumour after treatment with imatinib and sunitinib: European Organisation for Research and Treatment of Cancer phase II trial 1317 ‘CaboGIST.’ Eur J Cancer. 2020;1(134):62–74.

4. Martin-Broto J, Moura DS. New drugs in gastrointestinal stromal tumors. Curr Opin Oncol [Internet]. 2020 [cited 2021 Mar 21];32(4):314–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32453031

5. Wang Y, Call J. Mutational testing in gastrointestinal stromal tumor. Curr Cancer Drug Targets [Internet]. 2019 [cited 2021 May 19];19(9):688–97. Available from: https://pubmed.ncbi.nlm.nih.gov/30914028/

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gastrointestinal Stromal Tumors: 10-Year Experience in Cancer Center—The Ottawa Hospital (TOH);Current Oncology;2022-09-29

2. Locoregional Treatments for Metastatic Gastrointestinal Stromal Tumor in British Columbia: A Retrospective Cohort Study from January 2008 to December 2017;Cancers;2022-03-14